JPRN-UMIN000013318已完成未知
Efficacy of formoterol inhalation in patients with chronic obstructive pulmonary disease: investigation of the effects on the central and peripheral airways starting from immediately after inhalation - Bronchodilator effects on the central and peripheral airways of formoterol inhalation treatment (BENEFIT Study)
General incorporated association, Academy of Inhalation Methods (AIMs)0 个研究点目标入组 60 人开始时间: 2014年3月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with asthma 2) Treatment with oral corticosteroid 3) Insufficient inspiratory flow rate 4) Hospitalization within last 1 month 5) Emergency or unsheduled department visit for COPD within last 1 month 6) Respiratory infection within last 2 weeks 7) Cardiovascular disease 8) Lactating, pregnancy, or suspected pregnancy 9) Other unsuitable patients judged by the investigator
研究者
相似试验
已完成
3 期
Effect of Formoterol in treatment of covid19Condition 1: corona virus or COVID-19. Condition 2: COVID 19 ,virus not identified.COVID-19, virus identifiedCOVID-19, virus not identifiedU07.1U07.2IRCT20170210032478N3ational Research Institute of Tuberculosis and Lung Diseases200
尚未招募
Unknown
Role of Formoterol and Budesonide inhaler in childhood asthmaCTRI/2024/02/062290All India Institute of Medical Sciences, Rishikesh
已完成
不适用
Treatment with formoterol/budesonide in patients with asthmaAsthmaJPRN-UMIN000005185Hamamatsu University School of Medicine130
已完成
不适用
Clinical effects of budesonide/formoterol in patients with asthmaBronchial asthmaJPRN-UMIN000003745Atami Hospital International University of Health and Welfare30
撤回
2 期
Efficacy and Safety of Two Doses of Formoterol Fumarate MDI (PT005) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), Compared to Foradil® Aerolizer® as an Active ControlCOPDNCT01043601Pearl Therapeutics, Inc.